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MECHANISMS OF HYPERTENSION
SUBCLINICAL RENAL DAMAGE IS ASSOCIATED WITH A 
REDUCED CHOROIDAL THICKNESS IN PATIENTS WITH PRIMARY 
HYPERTENSION
G. Mule’1, M. Vadala’2, T. La Blasca1, R. Gaetani1, C. Pugliares1, L. Lattuca1,
M. Terrasi2, S. Cottone1. 1Unit of Nephrology and Hypertension; ESH excellence 
center; DIBIMIS; University of Palermo, Palermo, ITALY, 2Unit of Ophtalmology; 
Dipartimento di Biomedicina sperimentale e Neuroscienze cliniche, University of 
Palermo, Palermo, ITALY
Objective: The retina is considered the easiest accessible window to study the 
state of the systemic microcirculation, even if the choroid is the most important 
vascular layer of the eye. Our understanding of the choroid has been greatly in-
creased in last years since the introduction of advanced techniques of optical co-
herence tomography (OCT). Our study was aimed to assess choroidal thickness by 
using Swept-Source OCT (SS-OCT) in essential hypertensive patients (EHs) with 
and without subclinical renal damage (SRD).
Design and method: We enrolled 100 EHs of which 65 without kidney damage 
and 35 with SRD. In all the participants SS-OCT and a routine biochemical work-
up were performed. Glomerular fi ltration rate (GFR) was estimated by the CKD-
EPI equation (eGFR). SRD was defi ned, by the presence of microalbuminuria or 
eGFR between 30 and 60  mL/min/1.73 m2. OCT measurements were performed 
according to the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol, 
that divides the macula into 9 subfi elds. The circular grid consists of 3 concentric 
rings. The inner and outer rings are further divided into quadrants: temporal, na-
sal, superior, and inferior.
Furthermore, we calculated the average of the individuals values of the four quad-
rants separately for the inner and the outer ring. The average of all the 9 regions of the 
ETRDS grid (including the inner, the outer and the central rings) was also calculated.
Results: EHs with SRD showed thinner choroidal thicknesses than those without 
kidney damage (all p  <  0.05), even after adjustment for age (fi gure).Overall choroi-
dal thickness correlated signifi cantly and directly with eGFR (r  =  0.36) and nega-
tively with urinary albumin excretion (r  =  – 0.39). The association of choroidal 
thickness with SRD was confi rmed in multiple logistic regression analyses once 
the effect of age, anti-hypertensive therapy and triglycerides was accounted for. The 
odds ratio of having SRD associated with a standard deviation increase of overall 
choroidal thickness was 0.43 (0.24–0.75, 95% confi dence interval; p  =  0.007).
Conclusions: Our study confi rms the close relationships between changes in 
ocular microcirculation and renal dysfunction.
TRANSGLUTAMINASE-2 CONTRIBUTES TO REACTIVE OXYGEN 
SPECIES PRODUCTION IN MICE INFUSED WITH ANGIOTENSIN-II
S. Ucci, S. Chiandotto, C. Verga Falzacappa, A. Battistoni, A. Alonzo, M. Volpe, 
C. Savoia. Clinical and Molecular Medicine Department, Sapienza University of 
Rome, Rome, ITALY
Objective: Transglutaminase type II (TG2) is a pleiotropic enzyme that exhib-
its various activities and it is involved in diverse biological functions, including 
cell signaling, cytoskeleton rearrangements, displaying enzymatic activities. We 
previously demonstrated that TG2 may contribute to angiotensin II-induced re-
duction of NO bioavailability as well as to the impaired vascular functional and 
structural alterations induced by angiotensin II. Here we hypothesized that TG2 
may contribute to increased production of reactive oxygen species (ROS) in the 
vasculature of angiotensin-II-treated mice.
Design and method: TG2-knockout mice (TG2-K/O, 8weeks old, n  =  6) and age-
matched wild type (WT) control mice were treated or not with angiotensin-II. 
(400ng/kg/min) for 14 days. TG2 activity in aorta was measured by ELISA. ROS. 
production in aorta was evaluated by dihydroethidium staining. The expression of 
angiotensin type1 receptor (AT1R), TG2, NOX-1, and ERp72 (the positive modu-
lator of NOX-1) was evaluated in aorta by immunoblotting, coimmunoprecipita-
tion analysis was also performed.
Results: As expected, TG2-K/O lacked TG2 expression and activity. Angiotensin-
II signifi cantly increased (2-fold) TG2 expression and activity only in WT. AT1R 
expression in aorta was not infl uenced by Angiotensin II treatment in both WT and 
TG2K/O mice. ROS production was similar in WT and TG2-K/O and increased 
only in angiotensin-II-treated WT (+9%, p  <  0.01). NOX-1 and ERp72 expression 
was similar in WT and TG2-K/O. Angiotensin-II signifi cantly increased NOX-1 
(+23%, p  <  0.01) and ERp72 (+29%, p  <  0.01) only in WT. Only in aorta from 
WT and not from TG2-K/O, TG2 was successfully immunoprecipitated by AT1 
and ERP72, indicating that TG2 is able to interact with both proteins, and sug-
gesting that it may be involved in angiotensin II- induced NOX modulation and 
ROS production.
Conclusions: Angiotensin-II increased ROS production and NOX-1 expression 
and activation only in presence of TG2 in WT. TG2 interacts with both AT1R 
and ERp72. Thus, TG2 may contribute to NOX-induced ROS production in mice 
treated with angiotensin-II.
RETINAL ARTERIOLAR MICRO-CONSTRICTIONS EVALUATED 
WITH ADAPTIVE OPTICS: A NOVEL MARKER IN HYPERTENSION
A. Gallo1, X. Girerd1, D. Rosenbaum1, T. Dietenbeck2, N. Kachenoura2, 
M. Paques3. 1Cardiovascular Prevention Unit, University Hospital Pitié-Sal-
petrière, Paris, FRANCE, 2Laboratoire d Imagerie Biomedicale, Pierre-Marie 
Curie University, Paris, FRANCE, 3Institut de la vision - Centre d Investigation 
Clinique 503 Centre Hospitalier National des Quinze-Vingts, Paris, FRANCE
Objective: Retinal arteriolar remodeling is an early marker of subclinical target 
organ damage in arterial hypertension. Through adaptive optics which is totally 
noninvasive and highly accurate, it is possible to measure changes in arteriolar di-
ameter within 1  mm accuracy. The aim of this study was to evaluate a new marker 
describing internal diameter variability of the supero-temporal arteriole in hyper-
tensive patients before and after blood pressure control.
Design and method: Adaptive Optics RTX1® Camera (ImagineEye, Orsay, 
France) was used to capture three consecutive images along the supero-temporal 
arteriole. Wall Thickness (WT) and internal diameter (ID) were measured to cal-
culate Wall-to-Lumen Ratio (WLR) and Wall Cross-Sectional Area (WCSA). A 
coeffi cient of variation (CV) for ID was calculated for each group by the fol-
lowing formula: (standard deviation ID/mean ID)*100 over three consecutive 
measurements. Subjects with a CV ID  >  75% were classifi ed as irregular. Uncon-
trolled hypertensive subjects in the irregular group were given an antihypertensive 
pharmacological treatment and were reevaluated 1 month after.
Results: 44 patients were analyzed (mean age 47.7  ±  11). Median CV ID in the 
irregular group was 11% [IQR 9.0–15.0] as compared to 2.0% (regular group) 
[IQR 1.0–4.0], p  <  0.001. Patients in the arteriolar irregular group had an increase 
in home blood pressure (148.3/96.3 vs 130.7/ 82.6 mmHg, p  <  0.01). They had 
